Long-term growth hormone therapy in an adolescent boy with 45,X/46,XidicY(p11).
case_report · Level V
Where this comes from
- Record sourced from PubMed, PMID 19840619.
- Also identified by DOI 10.1016/j.jpeds.2009.03.018.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
A 17-year-old boy with chromosomal mosaicism resulting in a 45,X/46,X,idic(Y)(p11) karyotype came to medical attention at the age of 10 years because of short stature. He was treated with recombinant growth hormone for 6.6 years and has achieved a near final adult height of 172.5 cm. His clinical features included second-degree hypospadias, some stigmata of Turner syndrome, and spontaneous progression through puberty. We report long-term use of growth hormone in a male adolescent with isodicentric Yq.
Medical subject headings
- Body Height
- Growth Disorders
- Human Growth Hormone
- Noonan Syndrome